PubRank

Sharon L Hillier

Author PubWeight™ 142.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med 2015 9.20
2 Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV 2015 4.33
3 Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002 4.18
4 Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 2003 3.24
5 Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 2003 3.20
6 Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011 2.86
7 Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol 2006 2.56
8 Absence of ageism in access to critical care: a cross-sectional study. Age Ageing 2003 2.14
9 A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2008 2.09
10 Characterization of vaginal flora and bacterial vaginosis in women who have sex with women. J Infect Dis 2002 2.09
11 Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005 2.04
12 A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005 1.94
13 Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002 1.85
14 Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002 1.73
15 Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005 1.72
16 Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect 2007 1.70
17 Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis 2003 1.70
18 Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 2004 1.65
19 Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis 2004 1.65
20 Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 2007 1.63
21 Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005 1.60
22 Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID. Sex Transm Dis 2010 1.59
23 Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci U S A 2003 1.56
24 Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model. Sex Transm Dis 2002 1.54
25 Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception 2006 1.52
26 Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003 1.44
27 Glycosidase and proteinase activity of anaerobic gram-negative bacteria isolated from women with bacterial vaginosis. Sex Transm Dis 2003 1.38
28 The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 2006 1.35
29 Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One 2011 1.28
30 Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by strand displacement amplification and relevance of the amplification control for use with vaginal swab specimens. J Clin Microbiol 2003 1.26
31 Why women douche and why they may or may not stop. Sex Transm Dis 2003 1.26
32 Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004 1.24
33 The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study. J Acquir Immune Defic Syndr 2006 1.24
34 Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol 2002 1.24
35 Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis 2009 1.24
36 Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004 1.21
37 Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol 2004 1.20
38 Why nonoxynol-9 may have failed to prevent acquisition of Neisseria gonorrhoeae in clinical trials. Sex Transm Dis 2005 1.19
39 Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis 2005 1.16
40 Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol 2012 1.13
41 Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis. J Infect Dis 2007 1.12
42 DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 2003 1.11
43 Clinical and cervical cytokine response to treatment with oral or vaginal metronidazole for bacterial vaginosis during pregnancy: a randomized trial. Obstet Gynecol 2003 1.10
44 Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am J Obstet Gynecol 2003 1.09
45 Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women. Am J Epidemiol 2005 1.09
46 Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol 2002 1.09
47 Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. J Infect Dis 2009 1.08
48 Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003 1.08
49 Development of a nonhuman primate model for Trichomonas vaginalis infection. Sex Transm Dis 2006 1.08
50 Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque. Sex Transm Dis 2006 1.07
51 Quantitative survival of aerobic and anaerobic microorganisms in Port-A-Cul and Copan transport systems. J Clin Microbiol 2008 1.07
52 Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005 1.06
53 Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies. Cytokine 2011 1.05
54 Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol 2012 1.03
55 DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol 2005 1.03
56 Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 2009 1.03
57 Comparison of API 50 CH strips to whole-chromosomal DNA probes for identification of Lactobacillus species. J Clin Microbiol 2005 1.02
58 Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol 2012 1.01
59 Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol 2007 1.01
60 Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002 1.01
61 The vaginal inflammatory milieu and the risk of early premature preterm rupture of membranes. Am J Obstet Gynecol 2005 1.00
62 Permeability of tritiated water through human cervical and vaginal tissue. J Pharm Sci 2004 1.00
63 HIV-1 infection of female genital tract tissue for use in prevention studies. J Acquir Immune Defic Syndr 2013 0.99
64 Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance. J Antimicrob Chemother 2004 0.99
65 Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am J Obstet Gynecol 2007 0.99
66 Risk factors for cervicitis among women with bacterial vaginosis. J Infect Dis 2006 0.98
67 Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 2003 0.97
68 Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. Am J Obstet Gynecol 2003 0.97
69 Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003 0.97
70 Macaca fascicularis vs. Macaca nemestrina as a model for topical microbicide safety studies. J Med Primatol 2004 0.97
71 A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. J Acquir Immune Defic Syndr 2016 0.95
72 Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J Pharm Sci 2008 0.95
73 Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol 2010 0.94
74 Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005 0.93
75 Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women. J Clin Microbiol 2003 0.93
76 Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781. AAPS J 2008 0.93
77 Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis 2012 0.92
78 Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis 2013 0.92
79 Plasma versus serum for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies with a glycoprotein G2-based enzyme immunoassay. J Clin Microbiol 2003 0.92
80 Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure. AIDS Res Hum Retroviruses 2013 0.92
81 Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1. J Acquir Immune Defic Syndr 2014 0.91
82 Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin, and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol 2002 0.90
83 Incidence and epidemiology of Streptococcus pseudoporcinus in the genital tract. J Clin Microbiol 2010 0.90
84 Lactobacillus crispatus capsules: single-use safety study in the Macaca nemestrina model. Sex Transm Dis 2003 0.89
85 Pregnancy-induced changes in immune protection of the genital tract: defining normal. Am J Obstet Gynecol 2013 0.89
86 Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. Am J Obstet Gynecol 2009 0.88
87 Cervical anti-inflammatory cytokine concentrations among first-trimester pregnant smokers. Am J Obstet Gynecol 2005 0.88
88 Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) 2006 0.87
89 Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol 2006 0.87
90 A little bit pregnant: modeling how the accurate detection of pregnancy can improve HIV prevention trials. Am J Epidemiol 2008 0.87
91 Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine 2012 0.86
92 Microflora changes with the use of a vaginal microbicide. Sex Transm Dis 2002 0.86
93 Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention. Pharm Res 2014 0.86
94 The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota. AIDS 2013 0.85
95 Use of DNA hybridization to detect vaginal pathogens associated with bacterial vaginosis among asymptomatic pregnant women. Am J Obstet Gynecol 2005 0.84
96 Subtle perturbations of genital microflora alter mucosal immunity among low-risk pregnant women. Acta Obstet Gynecol Scand 2011 0.83
97 The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol 2007 0.83
98 Survival of Trichomonas vaginalis in wet preparation and on wet mount. Sex Transm Infect 2013 0.82
99 Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynecol 2006 0.80
100 Patterns of Extragenital Chlamydia and Gonorrhea in Women and Men Who Have Sex With Men Reporting a History of Receptive Anal Intercourse. Sex Transm Dis 2016 0.80
101 Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 2005 0.79
102 The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Transm Dis 2009 0.79
103 Haemophilus influenzae septic abortion. Infect Dis Obstet Gynecol 2002 0.79
104 Colposcopically obtained images of vulvar, vaginal, and cervical epithelium for assessment of safety of intravaginal agents among normal adolescent females: comparison with in vivo exam and interobserver agreement. J Low Genit Tract Dis 2003 0.79
105 Metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis: a dose-ranging study. J Low Genit Tract Dis 2015 0.79
106 Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals? AIDS 2016 0.78
107 Systemic immune response to Trichomonas vaginalis infection during pregnancy. Sex Transm Dis 2007 0.77
108 Preventing the sexual transmission of HIV-1 with topical microbicides: another piece of the equation. J Infect Dis 2007 0.77
109 Combined hormonal contraception may be protective against Neisseria gonorrhoeae infection. Sex Transm Dis 2010 0.77
110 Preferred characteristics of vaginal microbicides in women with bacterial vaginosis. J Womens Health (Larchmt) 2009 0.76
111 Prevalent, treatable and significant: barriers to the control of Trichomonas vaginalis in women. Sex Transm Infect 2013 0.75
112 Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci. Curr Microbiol 2014 0.75
113 Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial. J Acquir Immune Defic Syndr 2017 0.75
114 Lea's Shield: colposcopic and microbiological testing during 8 weeks of use. Contraception 2005 0.75